title: Association of resistin with metabolic syndrome in Indian subjects.
abstract: BACKGROUND
  The role of resistin in insulin sensitivity and metabolic syndrome has been controversial until now. Increased plasma/serum resistin levels are associated with metabolic syndrome and insulin resistance. The aim of this study was to investigate the relationship between serum resistin levels with markers of metabolic syndrome in males.
  
  
  METHODS
  A total of 386 male volunteers were enrolled in a case-control study. All of the enrolled volunteers were analyzed to confirm metabolic syndrome following the guidelines of National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) of 2001. Of the 386 volunteers, 192 were categorized as cases of metabolic syndrome, whereas 194 were registered as controls without metabolic syndrome. Volunteers enrolled in the study were analyzed for anthropometrical parameters, lipid profile status, insulin, insulin resistance, and resistin.
  
  
  RESULTS
  Higher levels of resistin were observed in cases when compared to controls (12.49 ± 4.73 ng/mL vs. 6.99 ± 1.98 ng/mL). Resistin was positively and significantly associated with serum triglyceride, cholesterol, and very-low-density lipoprotein, whereas it was negatively and significantly associated with serum high-density lipoprotein (HDL) levels. Multiple regression analysis of the data observed indicated that the triglyceride level was the major determinant for the development of metabolic syndrome in male samples.
  
  
  CONCLUSIONS
  This study demonstrates a positive correlation between resistin and factors of metabolic syndrome, except for HDL cholesterol (HDL-C), which was found to be negatively correlated in Indian male subjects. The study also found resistin to be a suitable peripheral blood marker.
authors.affiliation: Department of Physiology, CSMMU UP, Lucknow, India.
authors.forename: Arun K
authors.initials: AK
authors.lastname: Singh
authors.forename: Sunita
authors.initials: S
authors.lastname: Tiwari
authors.forename: Abhishek
authors.initials: A
authors.lastname: Gupta
authors.forename: Sunil M
authors.initials: SM
authors.lastname: Natu
authors.forename: Balraj
authors.initials: B
authors.lastname: Mittal
authors.forename: Aditya B
authors.initials: AB
authors.lastname: Pant
mesh_terms: D000328:Adult; D000886:Anthropometry / Q000379:methods; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D016022:Case-Control Studies; D002784:Cholesterol / Q000378:metabolism; D008076:Cholesterol, HDL / Q000378:metabolism; D006801:Humans; D007194:India; D007333:Insulin Resistance; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood* / Q000175:diagnosis / Q000208:ethnology; D010641:Phenotype; D012044:Regression Analysis; D052243:Resistin / Q000096:biosynthesis* / Q000097:blood*; D014280:Triglycerides / Q000378:metabolism
chemical_list: D015415:Biomarkers; D008076:Cholesterol, HDL; D008079:Lipoproteins, VLDL; D052243:Resistin; D014280:Triglycerides; D002784:Cholesterol